[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355083-105":59,"doc-detail-355083-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pathobiology-and-clinical-significance-of-malignant-pleural-effusions","Pathobiology and clinical significance of malignant pleural effusions","","Metastatic malignant pleural effusion (MPE) marks advanced-stage cancer through metastatic tumor foci within the pleural space, driving substantial morbidity and mortality. In the United States, more than 150,000 patients develop MPE annually, with a median survival of about 3–12 months. The review synthesizes current knowledge on MPE pathophysiology, focusing on intrinsic tumor-cell biology and tumor–immune pleural ecosystem interactions, and highlights research directions to improve clinical outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pathobiology-and-clinical-significance-of-malignant-pleural-effusions/355083/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pathobiology-and-clinical-significance-of-malignant-pleural-effusions/355083.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What defines metastatic malignant pleural effusion (MPE)?","Question",{"text":112,"@type":113},"MPE is defined by the establishment of metastatic tumor foci within the pleural space, leading to recurrent accumulation of malignant pleural fluid despite systemic treatment and drainage.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How common is MPE among lung cancer patients, and what survival does it carry?",{"text":117,"@type":113},"MPE occurs in about 15% of lung cancer patients at diagnosis and up to 50% with advanced-stage disease, and it is associated with a median survival of roughly 3–12 months.",{"name":119,"@type":110,"acceptedAnswer":120},"How is MPE diagnosed and what symptoms do patients often report?",{"text":121,"@type":113},"MPE is diagnosed by detecting malignant cells in pleural fluid cytology or pleural tissue biopsy, with imaging such as CT and ultrasound supporting assessment and planning. Patients commonly present with dyspnea, cough, and chest pain, though some cases are asymptomatic and found incidentally.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355083,1790747614,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Review Article  \nPathobiology and clinical signiﬁcance of malignant pleural effusions  \nAllison T Woods1,2,3,8, Abner A Murray2,3,4,8, Benjamin G Vincent 1,2,3,5 ✉, Jason Akulian 2,3,6 ✉ & Chad V Pecot 1,2,3,4,7 ✉  \nAbstract  \nMetastatic malignant pleural effusion (MPE) represents advancedstage cancer and is deﬁned by the establishment of metastatic tumor foci within the pleural space. It is most commonly associated with high degrees of morbidity and mortality. Annually, over 150,000 cancer patients in the United States develop MPE, which is associated with a dismal median survival of 3–12 months. As such, efforts must be made to understand the complex biological factors driving MPE pathophysiology. In this review, we discuss what is currently known and identify knowledge gaps regarding the intrinsic MPE biology of cancer cells and the heterotypic interactions between tumor cells and the immunologic pleural ecosystem. Furthermore, we discuss the clinical opportunities of studying MPE and identify promising directions for MPE research that may lead toa deeper understanding of the disease, ultimately aiming to enhance clinical outcomes for patients with advanced cancer.  \nKeywords Malignant Pleural Effusion; Non-small Cell Lung Cancer; Pleural Tumor Microenvironment; Tumor–Immune Interactions; Cancer Cellintrinsic Drivers  \nSubject Categories Cancer; Respiratory System  \n[https://doi.org/10.1038/s44321-025-00363-8](https://doi.org/10.1038/s44321-025-00363-8)  \nReceived 27 October 2025; Revised 10 November 2025; Accepted 13 November 2025  \nPublished online: 9 January 2026  \nIntroduction  \nThe pleura is a ﬁne, multilayered membrane that consists of the visceral pleura, which directly lines the lung parenchyma. At the hilum, this membrane reﬂects back onto and covers the chest wall, diaphragm, and mediastinum, becoming the parietal pleura. The pleural space is located between the visceral and parietal pleural membranes and contains small volumes (~5–15 mL) of serous ﬂuid (D’Agostino and Edens, 2025) . The pleural cavity has multiple physiological roles, acting as a lubricant and cushion for the lungs, providing augmentation of lung elastic recoil, and maintaining  \nnormal intrapleural pressure. Normally, pleural ﬂuid represents a homeostatic, sterile microenvironment; however, exogenous factors, including infection, trauma, stress, or disease (i.e., respiratory illness, cardiovascular or pulmonary events, or cancer), can alter its composition as well as that of the pleural space/lining. The accumulation of an abnormal collection of ﬂuid within the pleural space is called a pleural effusion. Pleural effusions are a result of disruptions within the homeostatic balance between production and/or drainage of pleural ﬂuid. The degree of disruption required to develop a pleural effusion should not be understated, as the pleural space can drain nearly thirty times more ﬂuid than what is typically produced (Antunes et al, 2003) .  \nWhile pleural effusion can be a complication of non-cancerous events occurring in the thoracic cavity, this review focuses on metastatic malignant pleural effusions (MPE), a hallmark of advanced-stage cancer and a clinically signiﬁcant endpoint in multiple malignancies. MPE are deﬁned by recurrent accumulation of large intrapleural ﬂuid collections that, despite systemic treatment and drainage, are ultimately associated with a high degree of morbidity and mortality (Shaikh et al, 2015) . In addition, MPE differs from the normal pleural space by the presence of tumor cells, inﬂammation (as indicated by elevated LDH and inﬂammatory mediators), elevated protein levels, and typically a lymphocyte-predominant cell count (MPE may also be neutrophilpredominant as well) (Jacobs et al, 2022) . MPE can occur in both the setting of primary pleural carcinoma (mesothelioma) and more commonly as metastasis from extra-pleural cancers, the most common being metastatic non-small cell lung cancer (NSCLC) and breast cancer (Fig. 1)","cbCaialKTYHVZVpQ","https://ap.wps.com/l/cbCaialKTYHVZVpQ","pdf",3040941,37,"English","# Abstract\n# Introduction\n## Pleural anatomy and homeostatic pleural fluid\n## Malignant pleural effusion: definition and clinical relevance\n## Diagnosis and common clinical presentation","[{\"question\":\"What defines metastatic malignant pleural effusion (MPE)?\",\"answer\":\"MPE is defined by the establishment of metastatic tumor foci within the pleural space, leading to recurrent accumulation of malignant pleural fluid despite systemic treatment and drainage.\"},{\"question\":\"How common is MPE among lung cancer patients, and what survival does it carry?\",\"answer\":\"MPE occurs in about 15% of lung cancer patients at diagnosis and up to 50% with advanced-stage disease, and it is associated with a median survival of roughly 3–12 months.\"},{\"question\":\"How is MPE diagnosed and what symptoms do patients often report?\",\"answer\":\"MPE is diagnosed by detecting malignant cells in pleural fluid cytology or pleural tissue biopsy, with imaging such as CT and ultrasound supporting assessment and planning. Patients commonly present with dyspnea, cough, and chest pain, though some cases are asymptomatic and found incidentally.\"}]","Pathobiology and clinical significance of malignant pleural effusions | PDF",1790115802,93,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b981615b2524945fd47bb5e5d12cdb6a.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52e5b301263984a5357ca58f0c4e26ce.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1690e39a4a88ab8dcfb96ba12aa3875b.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5b15e1da9f222a626d6458ab3f7e21b.webp",980,1301]